Clinical Trial: Effect of Avastin in Juxtafoveal Telangiectasias
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Does Avastin Change Evolution in Juxtafoveal Telangiectasias?
Brief Summary: Evaluation of efficacy of Intravitreal Injection of Bevacizumab in patients with Yuxtafoveal Telangiectasias
Detailed Summary: After diagnose Yuxtafoveal telangiectasias secondary to Branch Retinal Vein Occlusion and with Idiopathic Ethiology by clinical signs and Fluorescein angiogram (FA)findings we treated patients with Intravitreal Injection of Bevacizumab (2.5mg/0.1ml). We performed a complete ophthalmological evaluation and at baseline and follow-up (1 and 3 months) we evaluate ETDRS Best Corrected visual acuity (BCVA), fluorescein angiogram (FA) and Optical Coherence Tomography (OCT)findings. We found an improvement in visual acuity and reduction of FA leakage and decrease retinal thickness in OCT.
Sponsor: Asociación para Evitar la Ceguera en México
Current Primary Outcome:
- Best corrected Visual Acuity
- Fluorescein Angiogram: Leakage
- Optical Coherence Tomography: Retinal thickness
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Asociación para Evitar la Ceguera en México
Dates:
Date Received: November 30, 2006
Date Started: September 2006
Date Completion: November 2006
Last Updated: December 1, 2006
Last Verified: November 2006
